Management of Chronic Kidney Disease. A Clinician’s Guide.
- Second Edition
- Department of Nephrology, Faculty of Medicine Hacettepe University Ankara, Türkiye | Springer Nature Switzerland AG | 2023.
- 594 Pages Includes References and Index
The second edition of this essential work presents how to diagnose, treat and develop an appropriate management plan for patients with chronic kidney disease (CKD). Significantly updated chapters cover the fundamental sciences associated with CKD, its clinical assessment, evaluation, management of risk factors, along with cardiovascular disease in the context of CKD. Detailed insight is provided on how to assess for and manage a variety of CKD complications and special circumstances in CKD patients. The path to renal replacement therapy is also thoroughly described. New topics featured include associated rheumatic and electrolyte disorders. Furthermore, diagnostic and therapeutic approaches are presented according to the latest staging system for CKD, with patient care being discussed separately for each disease stage. The book also recognizes the needs of busy clinicians by including helpful boxes summarizing the evidence on diagnostic and therapeutic issues and practice pearls based upon the latest guidelines. Management of Chronic Kidney Disease: A Clinician’s Guide is a comprehensive practically applicable guide to the management of patients with CKD. Its didactic features enable the reader to quickly identify the key points covered and disseminate the information they require, making it a valuable resource for all practicing and trainee medical practitioners who encounter these patients.
978-3-031-42044-3 978-3-031-42045-0 (eBook)
= acute kidney injury advanced CKD albuminuria allopurinol anemia artery assessment associated blood pressure bone BP calcification cancer cardiac cause chronic kidney disease CKD patients CKD stage Clin clinical practice guideline cognitive comorbidities concentration coronary cystatin decreased depression diagnosis dialysis patients diet dietary disorders diuretics dose drug dysfunction effects eGFR erythropoietin ESKD evaluation excretion febuxostat Fig fluid GFR glomerular filtration rate heart failure hemodialysis https://doi hyperkalemia hypertension hyponatremia impairment Improving Global Outcomes increased risk infection inhibitors initiation intake kidney function Kidney Int levels m² medications ment meta-analysis metabolic acidosis mg mL/min mmHg monitoring mortality Nephrol Dial Transplant Nephrology nephropathy nutritional pain patients with chronic patients with CKD placebo PMID population potassium potential pregnancy prevalence progression protein proteinuria RAAS receptor recommended reduced renal replacement therapy risk factors serum creatinine sleep Soc Nephrol sodium statin stroke symptoms syndrome tion treatment trial type 2 diabetes uremic urinary urine vascular